|
Citation | Species | EC type | EC identification method | Septic treatment | Markers of apoptosis | Measure of trans-EC leak | Leak-apoptosis relationship | Comments |
|
Bannerman et al. 1998 [27] | Bovine | Commercial PAEC cell line | — | LPS | DNA laddering; TUNEL | 14C-albumin | +/− | Similar time course of leak and apoptosis; apoptosis inhibition (zVAD) did not affect leak |
Petrache et al. 2003 [28] | Bovine | Commercial PAEC cell line | — | TNFα | Annexin V; DNA laddering; cleaved caspase 8 | TEER | +/− | Apoptosis inhibition (zVAD) treatment inhibited leak; MLCK inhibition reduced apoptosis but did not affect leak |
Petrache et al. 2001 [29] | Human | Commercial PAEC | — | TNFα | Nucleosome ELISA | TEER | No | No apoptosis observed |
Liu et al. 2005 [30] | Human | Commercial HUVEC | — | LPS | DNA fragmentation; Annexin V | EB-albumin | +/− | Time-dependent relationship: leak at all time points, apoptosis only at later time points |
Seynhaeve et al. 2006 [31] | Human | Primary HUVEC | Morphology; CD31 | TNFα, IL1β, IFNγ | Annexin V; YO-PRO-1 | FITC-albumin | +/− | Variable leak-apoptosis relationship depending on combinations of different cytokines |
Cardoso et al. 2012 [32] | Rat | Primary brain MVEC | None | LPS | Nuclear morphology; caspase 3 activity | TEER; fluorescein | +/− | Leak-apoptosis correlation following LPS + other inflammatory stimuli, not LPS alone |
Lopez-Ramirez et al. 2012 [33] | Human | Commercial brain MVEC | — | TNFα, IFNγ | Annexin V; caspase 3/7 activity; TUNEL | TEER, FITC-dextran | +/− | Apoptosis inhibition (specific caspase inhibitors) only partially rescued leak; apoptosis only assessed at single time point |
Abdullah and Bayraktutan 2014 [34] | Human | Commercial brain MVEC | — | TNFα | TUNEL; caspase 3/7 activity | TEER; EB-albumin | +/− | Leak and apoptosis early; leak recovers at later time points but apoptosis increases |
Bechelli et al. 2015 [35] | Human | Commercial dermal MVEC cell line | — | Rickettsia conorii | Annexin V | TEER | No | Leak occurs before apoptosis; markers of other types of cell death present |
Yang et al. 2015 [36] | Human | Commercial pulmonary MVEC | — | LPS | Annexin V | FITC-dextran; FITC-albumin | +/− | Association at a single time point; some conditions had different effects on apoptosis and leak |
Wagner et al. 2016 [37] | Human | Commercial HUVEC | — | TNFα; procalcitonin | Annexin V | FITC-dextran | +/− | Leak early at low dose; apoptosis present later at high dose |
McDonnell et al. 2016 [38] | Human | Primary AoEC | None | Staphylococcus aureus | Annexin V | FITC-dextran | Yes | Association at only a single time point |
Zhu et al. 2016 [39] | Human | Commercial HUVEC | — | TNFα and CXCL10 | Cleaved caspase 3 | TEER | Yes | Association at only a single time point |
Wang et al. 2017 (present study) | Mouse | Primary pulmonary MVEC | CD31, CD34, CD176, CD202b | TNFα, IL1β, IFNγ | Annexin V; FLICA (pan-caspase activity); TUNEL | TEER, EB-albumin | Yes | Time-dependent relationship: early leak apoptosis-independent; delayed leak apoptosis-dependent |
|